Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chemo Sensitization with CXCR4 Antagonist in Acute Leukemia HSCT
NCT02605460Phase 2Unknown
- Sponsor
- Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
- Start
- Feb 2014
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of plerixafor in acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), sponsored by Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. Status: unknown.
02
Drugs
plerixafor
03
Conditions
acute myeloid leukemia (AML)acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT02605460.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02605460.